A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-
Article in Investigational New Drugs (December 2023)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Article in Investigational New Drugs (December 2023)
Article in Al Mustansiriyah Journal of Pharmaceutical Sciences (May 2023)
Article in Current Oncology (October 2022)